Title: EFFICACY OF USTEKINUMAB, VEDOLIZUMAB, OR A SECOND ANTI-TNF
AGENT AFTER THE FAILURE OF A FIRST ANTI-TNF AGENT IN PATIENTS WITH
CROHN’S DISEASE: A MULTICENTRE RETROSPECTIVE STUDY
Version: 5 Date: 15 Nov 2022
Reviewer's report:
Thanks for the replies and changes.
Title: EFFICACY OF USTEKINUMAB, VEDOLIZUMAB, OR A SECOND ANTI-TNF
AGENT AFTER THE FAILURE OF A FIRST ANTI-TNF AGENT IN PATIENTS WITH
CROHN’S DISEASE: A MULTICENTRE RETROSPECTIVE STUDY
Version: 5 Date: 15 Nov 2022
Reviewer's report:
Thanks for the replies and changes.
Please review this paper.
user
Title: EFFICACY OF USTEKINUMAB, VEDOLIZUMAB, OR A SECOND ANTI-TNF
AGENT AFTER THE FAILURE OF A FIRST ANTI-TNF AGENT IN PATIENTS WITH
CROHN’S DISEASE: A MULTICENTRE RETROSPECTIVE STUDY
Version: 5 Date: 15 Nov 2022
Reviewer's report:
Thanks for the replies and changes.
assistant